Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans.
Xenobiotica; the fate of foreign compounds in biological systems • Vol. 49, Issue 4 • 2019
Clinical Pharmacokinetics and Drug Interactions of Doravirine.
European journal of drug metabolism and pharmacokinetics • Vol. 43, Issue 6 • 2018
In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.
Antimicrobial agents and chemotherapy • Vol. 58, Issue 3 • 2014
HIV-1 reverse transcription.
Cold Spring Harbor perspectives in medicine • Vol. 2, Issue 10 • 2012
